Chambers Review
Provided by Chambers
UK
Corporate/M&A: £100-800 million - London (Firms)
Individual Editorial
Andrew Edge is a foremost corporate practitioner who is sought after by clients on their more significant transactions. He provides outstanding counsel on mid-market M&A and joint ventures.
Life Sciences: Transactional - UK-wide
Individual Editorial
Andrew Edge is highly regarded for his expertise in M&A and equity capital markets advising pharmaceuticals and biotechnology companies.